Vyoshadi Varlepa and Dhatrikhadirkwath Treatment in vitiligo
- Conditions
- Health Condition 1: L80- Vitiligo
- Registration Number
- CTRI/2024/07/070687
- Lead Sponsor
- Post Graduate Institute of Ayurved DSRRAU Jodhpur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Subjects of either sex will be taken.
Subjects having age between 25 to 50 years will be selected with chronicity of less than 10 years
Subjects having classical sign and symptoms of Shvitra Arunata, Mandala, Rukshata, Paridhvanshi for Vatik Shvitra.
Padampatra Pratikasham, Sadaha, Romavidhvanshi, Tamra for Paitika Shvitra.
Kandu, Shveta, Bahala, Snigdha for Shleshmika Shvitra.
Subjects having any systemic illness.
Subjects not willing to participate in the study.
Subjects having chronicity more than 10 years.
Subjects having serious cardiac, renal, hepatic diseases, other condition like
insulin dependent diabetes mellitus (IDDM) & non IDDM.
Gravid and lactating women were also excluded.
Subjects having patches due to burning or chemical explosion.
Subjects having lesions at Guhyanga (genital organ), Panipadatala (Sole of palm
and foot), Oshtha (Lips), Aekanga (generalized lesion), Sarvanga (generalized
lesion) and patches with Raktaroma (reddish hair) and Samsakta (coalescent).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome of this study was to evaluate and compare the efficacy of Vyoshadi Varlepa and Dhatrikhadira Kwatha in the treatment of Shvitra. The effectiveness of these treatments will be assessed based on the degree of repigmentation observed in depigmented patches, the reduction in the size of these patches, and overall improvement in skin health.Timepoint: 90 days
- Secondary Outcome Measures
Name Time Method The secondary outcomes of this study to evaluate additional aspects of the treatments effectiveness & their impact on the quality of life for patients with Shvitra (vitiligo). These included: <br/ ><br>Patient Quality of Life <br/ ><br>Patient Satisfaction <br/ ><br>Adverse Effects <br/ ><br>Pigmentation Stability <br/ ><br>Inflammation & Itching <br/ ><br>Timepoint: After complition of study every 15 days